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Background
Graft dysfunction after lung transplantation is typically
attributable to infection or rejection. In the absence of
these entities, structural cardiovascular (CV) abnormal-
ities need to be sought. At our center this evaluation
typically includes a myriad of diagnostic tests: echocar-
diography, chest computed tomographic angiography,
nuclear medicine lung perfusion imaging, and right
heart catheterization (RHC). This study was designed to
evaluate the utility of a novel comprehensive CMR pro-
tocol for identification of all post-operative structural
CV complications in lung transplant recipients.
Methods
We enrolled 80 consecutive lung transplant recipients
who were referred for CMR evaluation of CV abnormal-
ities. There were 47 men and 33 women; mean age 56.7
±13.6 years; 55 Caucasians, 9 Hispanic, 13 African
American, and 3 Asian. Underlying restrictive disease
was present in 39 subjects, obstructive disorders in 22,
and other disorders in 19. Forty-three subjects had
undergone double lung transplant, while 37 subjects had
single lung transplant (23 left lung, and 14 right lung).
The comprehensive CMR protocol included complete
short and long axis cine imaging (SSFP) to evaluate car-
diac size and function; ECG gated spin echo imaging to
assess pericardial thickness; contrast enhanced MRA of
the pulmonary arterial (PA) and venous (PV) systems to
assess for anastomotic site stenosis; phase contrast velo-
city flow mapping to assess anastomotic site peak velo-
city and right and left PA flow fraction; and inversion
recovery SSFP to evaluate for myocardial fibrosis.
Results
All 80 subjects completed CMR imaging without diffi-
culty and none were excluded from this analysis for rea-
sons of image quality. The mean LVEF was 66.4±9.23%,
mean RVEF was 54.37±10.45%, right and left PAs flow
were 2.6±1.21 and 2.6± 1.31 liter/min, respectively. Spe-
cific complications identified and the prevalence is
shown in Table 1. Patients with moderate or severe PA
or PV anastomotic site stenosis underwent RHC and
intravascular ultrasound, which confirmed CMR find-
ings; patients with severe stenosis underwent stenting of
the respective vessel. Patients with CMR evidence of
pericardial constriction underwent pericardiectomy with
improvement in symptoms.
Conclusions
A comprehensive CMR protocol can be a useful single
noninvasive test for the detection of structural cardio-
vascular (CV) abnormalities after lung transplantation.
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Table 1
Complication n (%)
PA Anastomotic Site Stenosis Moderate Stenosis (50-70%)
Severe Stenosis (> 70%)
6 (8%) 2
(3%)
PV Anastomotic Site Stenosis Moderate Stenosis (50-70%)
Severe Stenosis (> 70%)
1 (1%) 1
(1%)
Pericardial constriction 6 (8%)
Acquired pericardial cyst causing hemodynamic
compromise
2 (3%)
Myocardial fibrosis 24 (30%)
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